MENU
RZLT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rezolute (RZLT) Ownership - Who owns Rezolute?

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more

Profile

Industry
N/A
Address
275 Shoreline Drive
Phone
+1 650 206-4507
Employees
51
Web
https://www.rezolutebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
254.07M
P/E Ratio
N/A
Total Cash
152.19M
Projected Growth
N/A
Total Debt
1.45M
Revenue
N/A
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash/Share
1.64
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

RZLT
Capitalization
254M
P/E Ratio
N/A
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash
152M
Total Cash/Share
1.64
Total Debt
1.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
147M
P/B Ratio
1.73
Cash Flow
N/A
Earnings
-0.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
91K
Current Ratio
15.15
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-82.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.73
Shares Held By Institutions
1.23B
Shares Outstanding - Current
92.7M
Total Liabilities
11.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-44.082
View a ticker or compare two or three
RZLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RZLT showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
275 Shoreline Drive
Phone
+1 650 206-4507
Employees
51
Web
https://www.rezolutebio.com